Other was Thermo Fisher Scientific’s largest region in fiscal 2025, bringing in $22.32B of $43.84B (51%).
| Geography | FY 2009 | FY 2010 | FY 2012 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | — | — | — | $22.32B | |||||||
| North America | $24.59B | $22.76B | — | — | |||||||
| United States | — | — | $21.76B | — | |||||||
| Revenues | — | — | — | — | |||||||
| Europe | $10.76B | $10.74B | — | $11.83B | |||||||
| All Other Countries | — | — | — | — | |||||||
| Asia-Pacific | $8.12B | $7.87B | $7.96B | $8.10B | |||||||
| Asia Pacific | — | — | — | — | |||||||
| China | — | — | — | — | |||||||
| Other Regions | $1.44B | $1.48B | $1.56B | $1.60B | |||||||
| Total | $44.92B | $42.86B | $31.27B | $43.84B |
Thermo Fisher Scientific brought in $43.84B from its four regions in fiscal 2025, the year ended December 31, 2025. Thermo Fisher Scientific regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $31.27B. Other was the largest at $22.32B (50.9%), ahead of Europe at $11.83B (27.0%) and Asia-Pacific at $8.10B (18.5%). The remaining region, Other Regions, brought in $1.60B.
Compared with fiscal 2024, Other Regions grew 2.3% to $1.60B and Asia-Pacific grew 1.8% to $8.10B.
Thermo Fisher Scientific began breaking out Other in fiscal 2025, when it brought in $22.32B. Thermo Fisher Scientific stopped reporting North America ($22.76B in fiscal 2023) and United States ($21.76B in fiscal 2024) as separate regions.
Consumables was Thermo Fisher Scientific’s largest product and service line in fiscal 2025, bringing in $18.66B of $44.56B (42%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | $20.62B | $17.60B | $17.59B | $18.66B | ||||||
| Product | — | — | — | — | ||||||
| Service Revenues | $16.37B | $17.61B | $17.85B | $18.59B | ||||||
| Service | — | — | — | — | ||||||
| Instruments | $7.92B | $7.65B | $7.45B | $7.30B | ||||||
| Total | $44.92B | $42.86B | $42.88B | $44.56B |
Thermo Fisher Scientific brought in $44.56B from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 3.9% from $42.88B in fiscal 2024. Consumables was the largest at $18.66B (41.9%), ahead of Service Revenues at $18.59B (41.7%) and Instruments at $7.30B (16.4%).
Compared with fiscal 2024, Consumables grew fastest, up 6.1% to $18.66B, while Instruments fell the most, down 1.9% to $7.30B. From fiscal 2022 to 2025, combined revenue from these lines fell from $44.92B to $44.56B, a compound annual decline of 0.3%. Consumables' share of the total fell from 45.9% to 41.9%.
Pharma Services was Thermo Fisher Scientific’s largest segment in fiscal 2024, bringing in $6.69B of $31.08B (22%).
| Subsegments | FY 2024 |
|---|---|
| Pharma Services | $6.69B |
| Biosciences | $4.19B |
| Chromatography & Mass Spectrometry | $3.28B |
| Electron Microscopy | $2.87B |
| Genetic Sciences | $2.79B |
| Bioproduction | $2.65B |
| Laboratory Products | $2.53B |
| Healthcare Market Channel | $1.76B |
| Chemical Analysis | $1.32B |
| Clinical Diagnostics | $1.06B |
| Immunodiagnostics | $864.00M |
| Microbiology | $633.00M |
| Transplant Diagnostics | $454.00M |
| Total | $31.08B |
Thermo Fisher Scientific brought in $31.08B from its 13 segments in fiscal 2024, the year ended December 31, 2024. Pharma Services was the largest at $6.69B (21.5%), ahead of Biosciences at $4.19B (13.5%) and Chromatography & Mass Spectrometry at $3.28B (10.5%). The other 10 segments brought in $16.93B combined.
Thermo Fisher Scientific (TMO) reports its revenue by geography, by product and service and by subsegments. In fiscal 2025, Other was its largest region, bringing in $22.32B (50.9% of the total), followed by Europe at $11.83B (27.0%).
Other was Thermo Fisher Scientific's largest region in fiscal 2025, bringing in $22.32B, or 50.9% of the $43.84B total across its four regions.
Consumables was Thermo Fisher Scientific's largest product and service line in fiscal 2025, bringing in $18.66B, or 41.9% of the $44.56B total across its three product and service lines.
Pharma Services was Thermo Fisher Scientific's largest segment in fiscal 2024, bringing in $6.69B, or 21.5% of the $31.08B total across its 13 segments.
Among Thermo Fisher Scientific's product and service lines that make up at least 2% of revenue, Consumables grew fastest in fiscal 2025, up 6.1% from $17.59B to $18.66B.
Every figure comes from Thermo Fisher Scientific's annual financial filings, as reported. Each line keeps the name Thermo Fisher Scientific gives it, and years follow its fiscal calendar.
Thermo Fisher Scientific's revenue by geography goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.